Total Current Liabilities - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Total Current Liabilities Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Total Current Liabilities
â‚Ş225.9m
CAGR 3-Years
96%
CAGR 5-Years
69%
CAGR 10-Years
59%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Total Current Liabilities
$13B
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
1%
Redhill Biopharma Ltd
NASDAQ:RDHL
Total Current Liabilities
$21.2m
CAGR 3-Years
-36%
CAGR 5-Years
9%
CAGR 10-Years
23%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Total Current Liabilities
$5.2m
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Total Current Liabilities
$22.6m
CAGR 3-Years
33%
CAGR 5-Years
16%
CAGR 10-Years
22%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Total Current Liabilities
â‚Ş156.7m
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
0%

See Also

What is InterCure Ltd's Total Current Liabilities?
Total Current Liabilities
225.9m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Total Current Liabilities amounts to 225.9m ILS.

What is InterCure Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
59%

Over the last year, the Total Current Liabilities growth was -28%. The average annual Total Current Liabilities growth rates for InterCure Ltd have been 96% over the past three years , 69% over the past five years , and 59% over the past ten years .

Back to Top